Trial Profile
Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Jul 2023
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery restenosis; Myocardial infarction; Stroke
- Focus Therapeutic Use
- Acronyms EXCEL
- Sponsors Abbott Laboratories
- 22 Dec 2020 Results published in the American Journal of Cardiology
- 06 Oct 2020 Results published in the Journal of the American College of Cardiology
- 22 Apr 2020 Results assessing the association between smoking status and clinical outcomes among patients undergoing left main coronary artery (LM) revascularization by contemporary PCI or coronary artery bypass grafting (CABG) published in the American Journal of Cardiology